Related Experiment Video
Updated: Jan 10, 2026

Split Hybridization Probe Utilizing a DNA Fluorescent Light-up Aptamer as a Signal Reporter for Sequence-Specific Nucleic Acid Analysis
Published on: July 8, 2025
Programmable fluorescent aptamer-based RNA switches for rapid identification of point mutations
Zhaoqing Yan1,2,3,4, Yudan Li2,3, Amit Eshed1,3
1Department of Biomedical Engineering, Boston University, Boston, MA, USA.
Researchers developed fast aptamer-based reporters for single-nucleotide-specific identification and genotyping through hybridization (FARSIGHTs) for rapid genetic analysis. These RNA switches enable precise detection of single nucleotide polymorphisms, crucial for disease diagnosis and pathogen monitoring.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Single nucleotide polymorphisms (SNPs) are vital for genetic disorder identification, pathogen drug resistance assessment, and infection transmission prevention.
- Precise genotyping using RNA-based probes requires balancing sequence-specific recognition, RNA structural stability, and SNP-induced functional changes.
Purpose of the Study:
- To develop a rapid, specific, and multiplexed method for identifying target sequences with single-nucleotide resolution.
- To create RNA-based aptamer switches (FARSIGHTs) for efficient genotyping and mutation detection.
Main Methods:
- In silico design of aptamer-based RNA switches (FARSIGHTs).
- Demonstration of FARSIGHT probe activation within 5 minutes, independent of upstream amplification.
- Coupling FARSIGHTs with isothermal amplification for sensitive fluorescence-based detection of mutations.
Main Results:
- FARSIGHTs enable rapid (as little as 5 min), low-leakage, and multiplexed identification of target sequences with single-nucleotide specificity.
- Combined FARSIGHTs and isothermal amplification achieve attomolar detection of single nucleotide mutations with high fluorescence output.
- Successfully distinguished SARS-CoV-2 Omicron from Alpha, Beta, and Gamma variants with 100% accuracy in clinical saliva samples.
Conclusions:
- FARSIGHTs offer a versatile platform for rapid and accurate genotyping of virtually any target sequence.
- The technology is easily reprogrammable for emerging pathogens, with potential applications in point-of-care diagnostics and personalized healthcare.
More Related Videos
03:38Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
10:57Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018